Clinical Trials Directory

Trials / Unknown

UnknownNCT02191423

Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression

The Effect of Oxytocin on Brain Attachment and Empathy Networks, and the Association Between the Brain Response and Treatment Outcome of Brief Dyadic Psychotherapy - in Women Suffering From Postpartum Depression

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Rationale and Hypotheses of the Current Research: the investigators speculate that mothers suffering from PPD exhibit high levels of depression and low levels of OXT, hence experiencing the interaction with their child as less rewarding, which in turn promote further depressive symptoms and interfere with child development. While dyadic psychotherapy has been studied in this context, it is unknown which depressed women will respond to this type of therapy, and whether such a response is mediated by the pro-bonding effect of oxytocin. The aim of this study is three-fold: 1. To study the effect of the administration of a single dose (24IU) of oxytocin on cerebral circuit processing and connectivity of empathy and attachment. 2. To examine whether the clinical response of mothers suffering from postpartum depression to short term dyadic psychotherapy (based on improved mother-child interactions) can be predicted by a unique brain response pattern to oxytocin. 3. To assess the relationship between levels of oxytocin in mother and baby and the effectiveness of psychological dyadic treatment on mothers suffering from postpartum depression.

Conditions

Interventions

TypeNameDescription
DRUGOxytocinadministered pre-fMRI assessment
DRUGplaceboadministered pre-fMRI assessment
BEHAVIORALDyadic psychotherapy

Timeline

Start date
2015-01-01
Primary completion
2016-06-01
First posted
2014-07-16
Last updated
2014-07-16

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02191423. Inclusion in this directory is not an endorsement.